Pharmaceutical Quality (Industry)
1.0.0 - STU1

Pharmaceutical Quality (Industry), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/uv-dx-pq/ and changes regularly. See the Directory of published versions

## : Composition - Drug - example, risk - JSON Representation

Raw json | Download

    {
      "resourceType" : "Composition",
      "id" : "composition-drug-pq-risk",
      "meta" : //     Based on Accumulus FHIR Product Example - Drug Product
      {
        "profile" : [
          🔗 "http://hl7.org/fhir/uv/pharm-quality/StructureDefinition/Composition-drug-pq"
        ]
      },
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Composition</b><a name=\"composition-drug-pq-risk\"> </a><a name=\"hccomposition-drug-pq-risk\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Composition &quot;composition-drug-pq-risk&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Composition-drug-pq.html\">Composition - Drug PQ</a></p></div><p><b>status</b>: final</p><p><b>type</b>: Product Note - Summary for Risk of Impurities <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span></p><p><b>date</b>: 2023-10-01</p><p><b>author</b>: <a href=\"Organization-organization-drug-pq-ex1.html\">Organization/organization-drug-pq-ex1</a> &quot;AAA Molybdenum Products, Inc.&quot;</p><p><b>title</b>: 3.2.P.2.2.4 - Summary for Risk of Impurities</p></div>"
      },
      "status" : "final",
      "type" : {
        "text" : "Product Note - Summary for Risk of Impurities"
      },
      "subject" : [
        {
          🔗 "reference" : "MedicinalProductDefinition/medicinalproductdefinition-drug-product-pq-ex1"
        }
      ],
      "date" : "2023-10-01",
      "author" : [
        {
          🔗 "reference" : "Organization/organization-drug-pq-ex1"
        }
      ],
      "title" : "3.2.P.2.2.4 - Summary for Risk of Impurities",
      "section" : [
        {
          "text" : {
            "status" : "additional",
            "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n                <p>Text for the risk assessment of elemental impurities in the product</p>\n            </div>"
          }
        }
      ]
    }